2 May 2018

Leaf Patient Monitoring System recognized with Frost & Sullivan’s Technology Leadership Award

Smith & Nephew (NYSE:SNN; LSE:SN), the global medical technology business, is proud to announce that Frost & Sullivan has awarded Leaf Healthcare the 2018 Global Technology Leadership Award for its breakthrough wireless patient monitoring solutions.

The Leaf Patient Monitoring System is a comprehensive,  clinically-proven technology that helps significantly reduce the risk of pressure injuries.1 It consists of a wireless device that is adhered to a patient's chest to monitor the patient's position, orientation, movement and activity, and is distributed in the US by Smith & Nephew, also an investor in the company.  A randomized control trial (RCT) trial conducted at Stanford University and recently published in the International Journal of Nursing Studies showed that patients protected by the Leaf Patient Monitoring System were 73% less likely* to develop a pressure ulcer/injury.1

Each year, Frost & Sullivan presents the Technology Leadership Award to the company that demonstrates uniqueness in developing and leveraging new technologies that deliver significant customer value. This year, Leaf is the only award winner for patient mobility monitoring. “The Leaf Patient Monitoring Solution is a specialized healthcare tool that helps improve patient outcomes through minimizing immobility-related complications,” said Patrick Riley, Principal Analyst at Frost & Sullivan. “The Leaf Patient Monitoring System’s clinical efficacy, versatility, and proven client value clearly demonstrate why Leaf Healthcare earns the 2018 Frost & Sullivan Technology Leadership Award in the global patient mobility monitoring market.”

Pressure injuries are among the most common and costly hospital-acquired conditions, costing the US healthcare system $11 billion annually.2 The average incremental hospitalization cost of a hospital-acquired pressure injury (HAPI) is $8,014 per patient.3

Mike Zagger, Senior Vice President US Wound Management, Smith & Nephew, commented, “Smith & Nephew is focused on providing not just products to treat conditions, but also supporting healthcare professionals through leading edge technologies designed to support prevention as well. We are proud to provide this device, alongside our full suite of pioneering products, to support healthcare professionals and enable them to reduce the human and economic cost of wounds.”

For detailed product information, please consult the product’s Instructions for Use (IFU) prior to use.



Dave Snyder
+1 (978) 749-1440
Smith & Nephew plc

About Smith & Nephew

Smith & Nephew is a global medical technology business dedicated to supporting healthcare professionals in their daily efforts to improve the lives of their patients. With leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma & Extremities, Smith & Nephew has more than 15,000 employees and a presence in more than 100 countries. Annual sales in 2017 were almost $4.8 billion. Smith & Nephew is a member of the FTSE100 (LSE: SN, NYSE: SNN).

For more information about Smith & Nephew, please visit our corporate website www.smith-nephew.com, follow @SmithNephewplc on Twitter or visit SmithNephewplc on Facebook.com

About Leaf Healthcare, Inc.

Leaf Healthcare creates wireless patient monitoring solutions for healthcare providers seeking efficient, cost effective ways to improve patient safety and clinical outcomes. Its patient monitoring system wirelessly monitors patient position and movement and uses that data to improve patient safety, clinical efficiency, and patient outcomes. To learn more, visit www.leafhealthcare.com

Forward-looking Statements

This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith & Nephew, these factors include: economic and financial conditions in the markets we serve, especially those affecting health care providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers; competition for qualified personnel; strategic actions, including acquisitions and dispositions, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20-F, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith & Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith & Nephew are qualified by this caution. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith & Nephew's expectations.

◊ Trademark of Smith & Nephew. Certain marks registered US Patent and Trademark Office.


1. Pickham, D. et al. Effect of a wearable patient sensor on care delivery for preventing pressure injuries in acutely ill adults: A pragmatic randomized clinical trial (LS-HAPI study). International Journal of Nursing Studies 80 (2018) 12-19. https://www.ncbi.nlm.nih.gov/pubmed/29331656
2. Russo et al. Hospitalizations Related to Pressure Ulcers, 2006. HCUP Statistical Brief #64. December 2008. Agency for Healthcare Research and Quality, Rockville, MD. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb64.pdf.
3. Dreyfus J, Gayle J, Trueman P, Delhougne G, Siddiqui A. Assessment of risk factors associated with hospital-acquired pressure injuries and impact on the health care utilization and cost outcomes in US hospitals. Am J Med Qual. 2017:1062860617746471.